(Q43109520)

14 November 2017

0 references

Desensitization of patients with allergic reactions to immunosuppressives in the treatment of inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

14 November 2017

1 reference

1 reference

Burton I Korelitz

1

1 reference

14 November 2017

Babitha Reddy

series ordinal

2

1 reference

14 November 2017

Jason Bratcher

series ordinal

3

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Drug Safety

14 November 2017

published in

1 reference

14 November 2017

volume

9

1 reference

14 November 2017

issue

3

1 reference

14 November 2017

page(s)

379-382

1 reference

The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Azathioprine hypersensitivity. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903571626

10.1517/14740330903571626

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference